NEW YORK, March 15, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Alere, Inc. ("Alere" or "the Company") (NYSE: ALR). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at firstname.lastname@example.org or 212-697-6484.
This investigation concerns whether Alere and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act").
Alere Inc. is a provider of health information through diagnostic tests for infections such as HIV, tuberculosis, malaria and dengue. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments.
On March 15, 2016, Rueters reported that Alere, Inc., which has agreed to be acquired by Abbot Laboratories for 5.8 billion last month, said it had received a grand jury subpoena from the U.S. Department of Justice requesting documents relating to its sales practices in Africa, Asia and Latin America and matters associated with the U.S. Foreign Corrupt Practices Act. Alere also said that it would not be able to file its annual report for 2015 on time, but still expects the Abbott deal to close by the end of the year.
Following this news, on March 15, 2016, Alere shares were down nearly 7% at $49.80 per share in early trading, their biggest percentage loss in one month.
If you are aware of any facts relating to this investigation, or purchased shares of Alere, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!alr/s1i4l. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | firstname.lastname@example.org
SOURCE Bronstein, Gewirtz & Grossman, LLC